Difference between revisions of "Michael Callahan"
Liaton9000 (talk | contribs) (Added Zika Foundation) |
Liaton9000 (talk | contribs) |
||
| Line 18: | Line 18: | ||
===Zika=== | ===Zika=== | ||
| − | Callahan acted as CEO and co-founder of the [[Zika Foundation]].<ref> | + | Callahan acted as CEO and co-founder of the [[Zika Foundation]].<ref>''Our Team.'' Zika Foundation. Retrieved July 18, 2016, from https://web.archive.org/web/20160718194206/http://zikafoundation.org/our-team/</ref> |
In March 2014, Callahan co-authored a paper describing development of medical countermeasures to the [[Zika]] virus alongside [[Robert Malone]] and [[Jill Glasspool-Malone]], and others.<ref>Malone, R. W., Homan, J., Callahan, M. V., Glasspool-Malone, J., Damodaran, L., Schneider, A. D. B., Zimler, R., Talton, J., Cobb, R. R., Ruzic, I., Smith-Gagen, J., Janies, D., & Wilson, J. (2016). ''Zika Virus: Medical Countermeasure Development Challenges.'' PLOS Neglected Tropical Diseases, 10(3), e0004530. https://doi.org/10.1371/journal.pntd.0004530</ref> | In March 2014, Callahan co-authored a paper describing development of medical countermeasures to the [[Zika]] virus alongside [[Robert Malone]] and [[Jill Glasspool-Malone]], and others.<ref>Malone, R. W., Homan, J., Callahan, M. V., Glasspool-Malone, J., Damodaran, L., Schneider, A. D. B., Zimler, R., Talton, J., Cobb, R. R., Ruzic, I., Smith-Gagen, J., Janies, D., & Wilson, J. (2016). ''Zika Virus: Medical Countermeasure Development Challenges.'' PLOS Neglected Tropical Diseases, 10(3), e0004530. https://doi.org/10.1371/journal.pntd.0004530</ref> | ||
Revision as of 18:00, 2 March 2023
 Michael Callahan  | |
|---|---|
 | |
| Member of | Rhodes Scholar/1991 |
| Interests | • Zika • Ebola • COVID-19 |
Infectious diseases scientist | |
Dr. Michael Callahan is an American infectious diseases scientist. He is a staff physician at the Massachusetts General Hospital (MGH) and a clinical subject matter expert for international clinical trials for the Assistant Secretary of Public Health Preparedness (ASPR) of the United States Department of Health and Human Services (HHS).[1]
Activities
Callahan was recruited in 2004 by the Defense Advanced Research Projects Agency (DARPA) to run their $260M Accelerated Manufacture of Pharmaceuticals program dealing with pandemics and microbial resistance.
Zika
Callahan acted as CEO and co-founder of the Zika Foundation.[2]
In March 2014, Callahan co-authored a paper describing development of medical countermeasures to the Zika virus alongside Robert Malone and Jill Glasspool-Malone, and others.[3]
He published a followup study in August 2016 titled Zika Fetal Neuropathogenesis: Etiology of a Viral Syndrome, again with the Malones.[4]
Raul Diego suggested Michael Callahan was DARPA’s Man in Wuhan.[5]
References
- ↑ Michael Callahan. Vaccine & Immunotherapy Center. Retrieved March 2, 2023, from https://web.archive.org/web/20230302083941/https://advancingcures.org/vic-management-michael-callahan/
- ↑ Our Team. Zika Foundation. Retrieved July 18, 2016, from https://web.archive.org/web/20160718194206/http://zikafoundation.org/our-team/
- ↑ Malone, R. W., Homan, J., Callahan, M. V., Glasspool-Malone, J., Damodaran, L., Schneider, A. D. B., Zimler, R., Talton, J., Cobb, R. R., Ruzic, I., Smith-Gagen, J., Janies, D., & Wilson, J. (2016). Zika Virus: Medical Countermeasure Development Challenges. PLOS Neglected Tropical Diseases, 10(3), e0004530. https://doi.org/10.1371/journal.pntd.0004530
- ↑ Klase, Z. A., Khakhina, S., Schneider, A. D. B., Callahan, M. V., Glasspool-Malone, J., & Malone, R. (2016). Zika Fetal Neuropathogenesis: Etiology of a Viral Syndrome. PLOS Neglected Tropical Diseases, 10(8), e0004877. https://doi.org/10.1371/journal.pntd.0004877
- ↑ https://unlimitedhangout.com/2020/07/investigative-reports/darpas-man-in-wuhan/
